|

JAB-8263 Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1/2: 1

Top Sponsors

  • Jacobio Pharmaceuticals Co., Ltd.1

Indications

  • MF1
  • ESCC1
  • CRPC1
  • Malignant Tumor1
  • Aml1

Other1 trial

A First-in-Human, JAB-8263 in Adult Patients With Advanced Tumors
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.